Development of a BCS Class II Drug Microemulsion for Oral Delivery: Design, Optimization, and Evaluation

Table 3

Formulation plan.

Run	Formulation plan				Responses
	% S	% CoS	% oil	% water
1	6.45	2.15	0.40	91	228	-9.78
2	30	10	0.40	59.60	324	-16.16
3	6.45	2.15	5.00	86.40	123	-10.6
4	30	10	5.00	55.00	221	-8
5	6.45	2.15	2.70	88.70	105	-11.94
6	30	10	2.70	57.30	170	-11.32
7	18.225	6.075	0.40	75.30	200	-14.33
8	18.225	6.075	5.00	70.70	51	-8.67
9	18.225	6.075	2.70	73.00	55	-17.6
10	18.225	6.075	2.70	73.00	56	-17.9
11	18.225	6.075	2.70	73.00	54	-17.5
12	18.225	6.075	2.70	73.00	53.00	-17.65